Mereo BioPharma (MREO) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	2.11K
Accounts receivable	9.7K
Inventories	34.23K
Prepaid expenses	3.74K
Total current assets	49.79K
PROPERTY AND EQUIPMENT, net of accumulated depreciation	402.62K
PATENTS AND TRADEMARKS, net of accumulated amortization	9.64K
TOTAL ASSETS	462.05K
Current portion of note payable	39.63K
Current portion of convertible notes payable - related party	97K
Accounts payable	339.11K
Accrued expenses	63.68K
Due to officers	70.5K
Other current liabilities	12K
Dividends on convertible redeemable preferred shares	11.03K
Notes payable to related party	10K
Total current liabilities	642.94K
LONG TERM LIABILITIES
Notes payable, less current portion	263.75K
MANDATORILY REDEEMABLE PREFERRED STOCK	18.26K
Total liabilities	1.69M
Preferred stock, $.01 par value, 50,000,000 shares authorized no shares issued or outstanding	0
Common stock, no par value: 100,000,000 shares authorized, 31,969,427 shares issued and outstanding	10.85M
Additional paid-in capital	1.71M
Accumulated deficit	-13.79M
Total stockholder's (deficit)	-1.23M
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT)	462.05K
LONG TERM LIABILITIES
CONVERTIBLE NOTES PAYABLE:	533.35K
LONG TERM LIABILITIES
CONVERTIBLE NOTES PAYABLE:	100K
LONG TERM LIABILITIES
MANDATORILY REDEEMABLE PREFERRED STOCK	130K

Entities mentioned with MREO

View All Entities